T80.A1 Non-ABO incompatibility with hemolytic transfusion reaction

Name of the Condition

• Non-ABO incompatibility with hemolytic transfusion reaction.

Summary

This condition describes an adverse reaction resulting from the transfusion of blood or blood products that is not due to ABO blood group incompatibility, specifically involving hemolysis. It occurs when the recipient’s immune system reacts to non-ABO antigens in the transfused material, leading to the destruction of red blood cells and associated clinical manifestations.

Causes

Non-ABO incompatibility with hemolytic transfusion reactions can arise from immune responses to minor blood group antigens, such as Rh, Kell, Duffy, or Kidd systems, or antibodies against platelet or plasma proteins. These reactions may be triggered by prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Renal impairment or oliguria

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history, performing direct antiglobulin testing, antibody screening, or crossmatching to identify non-ABO antigen incompatibilities. Laboratory tests may show evidence of hemolysis, such as elevated bilirubin, decreased haptoglobin, or increased lactate dehydrogenase.

Treatment Options

Treatment focuses on discontinuing the transfusion, managing symptoms (e.g., antihistamines for allergic reactions, fluids for hypotension), and addressing hemolysis (e.g., supportive care, renal protection). Severe cases may require intensive monitoring or additional interventions.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most mild cases resolve with supportive care, while severe hemolysis may lead to complications like acute kidney injury. Follow-up includes monitoring for delayed reactions and ensuring appropriate documentation of the event.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Recurrent transfusion reactions if sensitization persists

Lifestyle & Prevention

• Ensure thorough pre-transfusion antibody screening, especially in patients with prior transfusions or pregnancies.
• Use crossmatched blood products when possible.
• Educate patients on reporting symptoms during or after transfusions promptly.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, shortness of breath, or dark urine occur during or after a blood transfusion. These may indicate a hemolytic reaction requiring urgent evaluation.

Tips for Medical Coders

Document the specific non-ABO antigen involved (if known), the presence of hemolysis, and the transfusion context. Ensure the code T80.A1 is used when the reaction is explicitly identified as hemolytic and non-ABO related. Include details on the transfusion product, timing of the reaction, and any associated complications to support accurate coding.